tiprankstipranks
Advertisement
Advertisement

PSTV Stock Latest News

Plus Therapeutics to change name, ticker symbol
The FlyPlus Therapeutics to change name, ticker symbol
13d ago
PSTV
Plus Therapeutics Launches New At-The-Market Equity Program
PremiumCompany Announcements
Plus Therapeutics Launches New At-The-Market Equity Program
1M ago
8K
PSTV
Plus Therapeutics files $100M mixed securities shelf
PremiumThe Fly
Plus Therapeutics files $100M mixed securities shelf
1M ago
PSTV
Plus announces presentation of health economics study on CNSide CSF assay
PremiumThe Fly
Plus announces presentation of health economics study on CNSide CSF assay
2M ago
PSTV
Plus Therapeutics enters pact with Ephemeral for AI execution platform
PremiumThe Fly
Plus Therapeutics enters pact with Ephemeral for AI execution platform
2M ago
PSTV
Plus Therapeutics Stockholders Back Directors and Incentive Plan
PremiumCompany AnnouncementsPlus Therapeutics Stockholders Back Directors and Incentive Plan
2M ago
8K
PSTV
Plus Therapeutics reports Q1 EPS ($1.05), consensus (87c)
Premium
The Fly
Plus Therapeutics reports Q1 EPS ($1.05), consensus (87c)
2M ago
PSTV
Plus Therapeutics Regains Nasdaq Listing Compliance After Reverse Split
Premium
Company Announcements
Plus Therapeutics Regains Nasdaq Listing Compliance After Reverse Split
3M ago
8K
PSTV
Plus Therapeutics regains compliance with Nasdaq minimum bid price requirement
PremiumThe Fly
Plus Therapeutics regains compliance with Nasdaq minimum bid price requirement
3M ago
PSTV
PSTV Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
PSTV Upcoming Earnings Report: What to Expect?
3M ago
PSTV
Plus Therapeutics Appoints New Chief Development Officer
PremiumCompany Announcements
Plus Therapeutics Appoints New Chief Development Officer
3M ago
8K
PSTV
Plus Therapeutics appoints Eric Daniels as chief development officer
PremiumThe Fly
Plus Therapeutics appoints Eric Daniels as chief development officer
3M ago
PSTV
Plus Therapeutics Gains FDA Orphan Status for REYOBIQ
PremiumCompany AnnouncementsPlus Therapeutics Gains FDA Orphan Status for REYOBIQ
3M ago
8K
PSTV
Plus Therapeutics granted Orphan Drug Designation for Reyobiq
Premium
The Fly
Plus Therapeutics granted Orphan Drug Designation for Reyobiq
3M ago
PSTV
Plus Therapeutics price target lowered to $12 from $37.50 at Maxim
Premium
The Fly
Plus Therapeutics price target lowered to $12 from $37.50 at Maxim
3M ago
PSTV
Plus CNSide Cerebrospinal Fluid Tumor Cell Enumeration test gets AMA PLA code
PremiumThe Fly
Plus CNSide Cerebrospinal Fluid Tumor Cell Enumeration test gets AMA PLA code
3M ago
PSTV
Plus Therapeutics’ treatment of malignant glioma granted FDA orphan designation
PremiumThe Fly
Plus Therapeutics’ treatment of malignant glioma granted FDA orphan designation
3M ago
PSTV
Plus Therapeutics Enacts Reverse Stock Split to Maintain Listing
PremiumCompany Announcements
Plus Therapeutics Enacts Reverse Stock Split to Maintain Listing
3M ago
8K
PSTV
Plus Therapeutics Inc (USA) trading halted, news pending
PremiumThe Fly
Plus Therapeutics Inc (USA) trading halted, news pending
3M ago
PSTV
Plus Therapeutics downgraded to Hold from Buy at D. Boral Capital
PremiumThe FlyPlus Therapeutics downgraded to Hold from Buy at D. Boral Capital
3M ago
PSTV
Plus Therapeutics announces 1-for-25 reverse stock split
Premium
The Fly
Plus Therapeutics announces 1-for-25 reverse stock split
3M ago
PSTV
Plus Therapeutics Adds Industry Veteran Ronald Andrews to Board
Premium
Company Announcements
Plus Therapeutics Adds Industry Veteran Ronald Andrews to Board
4M ago
8K
PSTV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >